Cellegy targets women and testosterone

Many biotech companies choose their drug projects based on unmet medical needs, making the potential market largely a question of patient population and market penetration. By contrast, Cellegy Pharmaceuticals Inc. is starting a Phase I trial with its Tostrelle transdermal testosterone gel

Read the full 429 word article

How to gain access

Continue reading with a
two-week free trial.